Zymeworks (ZYME) Change in Taxes (2022 - 2026)
Zymeworks (ZYME) posted Change in Taxes of -$16000.0 for Q1 2026, up 98.29% sequentially from -$933000.0 in Q4 2025, and down 1500.0% YoY from $1142.9 in Q1 2025.
Powered by 
Analysis
Zymeworks (ZYME) Change in Taxes (2022 - 2026) Analysis & Trends
Zymeworks has reported Change in Taxes for 5 years, with the latest figure at -$16000.0 in Q1 2026.
- Quarterly Change in Taxes fell 1500.0% year-over-year to -$16000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$60000.0 (up 96.54% YoY) and the FY2025 annual result came in at -$45000.0, up 97.32% from the prior year.
- Change in Taxes improved to -$16000.0 in Q1 2026 per ZYME's latest filing, from -$933000.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $979000.0 in Q4 2023 and troughed at -$1.9 million in Q4 2024.
- A 5-year average of $5153.8 and a median of $50000.0 in 2024 frame the typical range for Change in Taxes.
- The sharpest annual moves came in 2025 and 2026: Change in Taxes soared 567.88% in 2025, then plunged 1500.0% in 2026.
- Over 5 years, Change in Taxes stood at $840000.0 in 2022, then advanced by 16.55% to $979000.0 in 2023, then tumbled by 298.47% to -$1.9 million in 2024, then jumped by 51.98% to -$933000.0 in 2025, then soared by 98.29% to -$16000.0 in 2026.
- According to Business Quant data, Change in Taxes over the past three periods registered -$16000.0, -$933000.0, and $915000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | - |
| 10 | Zymeworks | 2.13 Bn | 1.86 Bn | - | -22,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -22,000.00 |
| Mar 31, 2026 | -16,000.00 |
| Dec 31, 2025 | -933,000.00 |
| Sep 30, 2025 | 915,000.00 |
| Jun 30, 2025 | -26,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Dec 31, 2024 | -1.94 Mn |
| Sep 30, 2024 | 137,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 979,000.00 |
| Sep 30, 2023 | -327,000.00 |
| Jun 30, 2023 | 318,000.00 |
| Dec 31, 2022 | 840,000.00 |